News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
94,975 Results
Type
Article (2685)
Company Profile (8)
Press Release (92282)
Section
Business (39319)
Career Advice (75)
Deals (5680)
Drug Delivery (7)
Drug Development (11090)
Employer Resources (9)
FDA (1987)
Job Trends (2347)
News (55544)
Policy (3220)
Tag
Academia (175)
Accelerated approval (2)
Adcomms (3)
Allergies (17)
Alliances (3118)
ALS (18)
Alzheimer's disease (209)
Antibody-drug conjugate (ADC) (25)
Approvals (2066)
Artificial intelligence (25)
Autoimmune disease (4)
Bankruptcy (17)
Best Places to Work (2217)
Biosimilars (7)
Biotechnology (7)
Bladder cancer (28)
Brain cancer (5)
Breast cancer (103)
Cancer (627)
Cardiovascular disease (51)
Career advice (63)
Career pathing (4)
CAR-T (28)
Cell therapy (79)
Cervical cancer (5)
Clinical research (10151)
Collaboration (101)
Company closure (2)
Compensation (68)
Complete response letters (4)
COVID-19 (187)
CRISPR (9)
C-suite (23)
Cystic fibrosis (12)
Data (819)
Depression (12)
Diabetes (64)
Diagnostics (879)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (18)
Drug pricing (24)
Duchenne muscular dystrophy (20)
Earnings (35387)
Editorial (1)
Employer resources (7)
Events (11381)
Executive appointments (50)
FDA (2526)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (63)
Gene editing (16)
Generative AI (1)
Gene therapy (48)
GLP-1 (120)
Government (399)
Guidances (258)
Healthcare (2658)
HIV (7)
Huntington's disease (3)
IgA nephropathy (13)
Immunology and inflammation (20)
Immuno-oncology (1)
Indications (10)
Infectious disease (200)
Inflammatory bowel disease (14)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (10)
Interviews (9)
IPO (4167)
IRA (4)
Job creations (245)
Job search strategy (55)
Kidney cancer (3)
Labor market (18)
Layoffs (49)
Legal (456)
Liver cancer (11)
Longevity (1)
Lung cancer (117)
Lymphoma (74)
Machine learning (1)
Management (3)
Manufacturing (43)
MASH (34)
Medical device (2137)
Medtech (2141)
Mergers & acquisitions (1598)
Metabolic disorders (166)
Multiple sclerosis (18)
NASH (4)
Neurodegenerative disease (17)
Neuropsychiatric disorders (8)
Neuroscience (331)
NextGen: Class of 2025 (691)
Non-profit (447)
Now hiring (4)
Obesity (70)
Opinion (12)
Ovarian cancer (14)
Pain (7)
Pancreatic cancer (23)
Parkinson's disease (21)
Partnered (4)
Patents (25)
Patient recruitment (31)
Peanut (12)
People (2612)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase I (2349)
Phase II (4068)
Phase III (4386)
Pipeline (1146)
Policy (11)
Postmarket research (449)
Preclinical (697)
Press Release (4)
Prostate cancer (33)
Psychedelics (4)
Radiopharmaceuticals (43)
Rare diseases (70)
Real estate (335)
Recruiting (3)
Regulatory (2788)
Reports (13)
Research institute (198)
Resumes & cover letters (13)
Rett syndrome (1)
RNA editing (1)
RSV (3)
Schizophrenia (25)
Series A (6)
Series B (7)
Sickle cell disease (18)
Special edition (4)
Spinal muscular atrophy (13)
Sponsored (2)
Startups (163)
Stomach cancer (2)
Supply chain (5)
Tariffs (7)
Vaccines (80)
Venture capital (5)
Weight loss (39)
Women's health (4)
Worklife (4)
Date
Last 7 days (62)
Last 30 days (244)
Last 365 days (5347)
2025 (4053)
2024 (6273)
2023 (6794)
2022 (10112)
2021 (10882)
2020 (9606)
2019 (6350)
2018 (4801)
2017 (4618)
2016 (3887)
2015 (4799)
2014 (3304)
2013 (1984)
2012 (2216)
2011 (2316)
2010 (2362)
Location
Africa (42)
Alabama (4)
Arizona (21)
Asia (4808)
Australia (534)
California (1454)
Canada (412)
China (124)
Colorado (70)
Connecticut (93)
Delaware (89)
Europe (12555)
Florida (196)
Georgia (52)
Idaho (5)
Illinois (97)
India (3)
Indiana (84)
Japan (80)
Kansas (17)
Kentucky (6)
Louisiana (6)
Maine (38)
Maryland (191)
Massachusetts (1120)
Michigan (47)
Minnesota (65)
Mississippi (1)
Missouri (19)
Montana (4)
Nevada (6)
New Hampshire (10)
New Jersey (619)
New York (448)
North Carolina (179)
North Dakota (1)
Northern California (668)
Ohio (28)
Oregon (2)
Pennsylvania (318)
Rhode Island (1)
South America (112)
South Carolina (2)
Southern California (630)
Tennessee (11)
Texas (183)
United States (5568)
Utah (50)
Virginia (22)
Washington D.C. (16)
Washington State (137)
West Virginia (1)
Wisconsin (7)
94,975 Results for "34".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
October 6, 2025
·
5 min read
Press Releases
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025
September 16, 2025
·
5 min read
Press Releases
Slingshot Biosciences Launches TruCytes™ Potency CD20 & CD34 Stem Cell Gating Controls, Standardizing Critical Readouts While Slashing Variability, Time, and Cost
October 3, 2025
·
2 min read
Press Releases
Prostate Cancer Treatment Market Size to Reach USD 34.28 Billion by 2034
July 18, 2025
·
1 min read
Press Releases
GMP Plasmid DNA Market Size to Surpass USD 608.57 Million at 9.34% CAGR by 2034
June 13, 2025
·
1 min read
Press Releases
Automatic Aseptic Sampling Market Size Grows at 19.34% CAGR Driven by Sterility and Automation Demands, says Life Science Expert
June 23, 2025
·
1 min read
Press Releases
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
June 27, 2025
·
8 min read
Pharm Country
Tiziana Receives $3.4 Million in Non-Dilutive Funding
Tiziana Life Sciences, Ltd., a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes announced that it had received non-dilutive funding of $3.4 million and issued a corporate update video available here.
June 28, 2024
·
2 min read
Press Releases
Hemoglobinopathies Market Size to Hit USD 34.76 Billion by 203
February 26, 2025
·
1 min read
Press Releases
Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 3 Launch-HTN Trial at 34th European Meeting on Hypertension and Cardiovascular Protection
May 20, 2025
·
5 min read
1 of 9,498
Next
